Meet our experts

Our team

With Arex, you have a full suite of expertise at your fingertips. 

Linda Thunell

Founding partner
CEO

MSc Tox

Staffan Thunell

Founding partner

BSc Economics and BA

Erik Hedner

Founding Partner
Director Drug Development

PhD Med Chem and MBA

Lovisa Rosenquist

Founding partner
Director Post-Marketing Projects

BSc Mol Cell Biol

Catarina Edfjäll

Senior Advisor
Based in Basel, Switzerland

 PhD in Biochemistry

Linda Thunell

Founding partner
CEO

MSc Tox

During her 25 years in the pharma­ceutical industry Linda has held various executive positions, and between 2002 and 2019 she was the founder and CEO of Sofus Regulatory Affairs AB. She has also worked as Head of Regulatory Affairs in pharma companies and as assessor at the Swedish Medical Products Agency.

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.

Erik Hedner

Founding partner
Director Drug Development

PhD Med Chem and MBA

Erik specialises in areas related to drug development and regulatory CMC. After a PhD in Medicinal Chemistry he worked as a CMC assessor at the Swedish Medicinal Products Agency. He has since held various expert positions within pharma consulting, primarily with a focus on CMC in phase I-III projects.

Lovisa Rosenquist

Founding partner
Director Post-Marketing Projects

BSc Mol Cell Biol

Lovisa is a senior regulatory project manager with extensive experience from leading positions at consult­ancies, managing Nordic as well as global projects. She specialises in assisting companies with market entry and product launch activities. Lovisa started her career at the European Medicines Agency (EMA).

Catarina Edfjäll

Senior Advisor
Based in Basel, Switzerland

PhD in Biochemistry

Catarina has more than 25 years’ experience in global regulatory affairs and regulatory intelligence. She has held leadership roles within CSL Behring, Roche, Celgene (now BMS) and other international pharma and biotech companies. She has been responsible for the marketing authorization of over 20 innovative products and new indications (including for orphan drugs), reorganized global regulatory affairs departments and led successful health authority negotiations.